1887

Abstract

Hepatitis C virus (HCV) infection affects about 3 % of the human population. Phylogenetic analyses have grouped its variants into six major genotypes, which have a star-like distribution and several minor subtypes. The most abundant genotype in Europe is the so-called genotype 1, with two prevalent subtypes, 1a and 1b. In order to explain the higher prevalence of subtype 1b over 1a, a large-scale sequence analysis (100 virus clones) has been carried out over 25 patients of both subtypes in two regions of the HCV genome: one comprising hypervariable region 1 and another including the interferon sensitivity-determining region. Neither polymorphism analysis nor molecular variance analysis (attending to intra- and intersubtype differences, age, sex and previous history of antiviral treatment) was able to show any particular difference between subtypes that might account for their different prevalence. Only the demographic history of the populations carrying both subtypes and analysis of molecular variance (AMOVA) for risk practice suggested that the route of transmission may be the most important factor to explain the observed difference.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82277-0
2007-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/1/123.html?itemId=/content/journal/jgv/10.1099/vir.0.82277-0&mimeType=html&fmt=ahah

References

  1. Abe K., Inchauspe G., Fujisawa K. 1992; Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan. J Gen Virol 73:2725–2729 [CrossRef]
    [Google Scholar]
  2. Akaike H. 1974; A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723 [CrossRef]
    [Google Scholar]
  3. Bolumar F., Hernández-Aguado I., Ferrer L., Ruiz I., Avino M. J., Rebagliato M. 1996; Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990–1992. Int J Epidemiol 25:204–209 [CrossRef]
    [Google Scholar]
  4. Bracho M. A., García-Robles I., Jiménez N., Torres-Puente M., Moya A., González-Candelas F. 2004; Effect of oligonucleotide primers in determining viral variability within hosts. Virol J 1:13 [CrossRef]
    [Google Scholar]
  5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362 [CrossRef]
    [Google Scholar]
  6. Cochrane A., Simmonds P. 2002; Molecular epidemiology of hepatitis C virus. In The Molecular Epidemiology of Human Viruses pp  197–216 Edited by Leiner T. Dordrecht: Kluwer Acadademic;
    [Google Scholar]
  7. Domínguez A., Bruguera M., Vidal J., Plans P., Salleras L. 2001; Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 65:688–693 [CrossRef]
    [Google Scholar]
  8. Donahue J. G., Muñoz A., Ness P. M., Brown D. E. Jr, Yawn D. H., McAllister H. A. Jr, Reitz B. A., Nelson K. E. 1992; The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369–373 [CrossRef]
    [Google Scholar]
  9. Excoffier L., Smouse P. E., Quattro J. M. 1992; Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131:479–491
    [Google Scholar]
  10. Forns X., Maluenda M. D., López-Labrador F. X., Ampurdanes S., Olmedo E., Costa J., Simmonds P., Sanchez-Tapias J. M., Jimenez De Anta M. T., Rodes J. 1996; Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 34:2516–2521
    [Google Scholar]
  11. Griffiths R. C., Tavaré S. 1994; Sampling theory for neutral alleles in a varying environment. Philos Trans R Soc Lond B Biol Sci 344:403–410 [CrossRef]
    [Google Scholar]
  12. Holmes E. C. 2003; Molecular clocks and the puzzle of RNA virus origins. J Virol 77:3893–3897 [CrossRef]
    [Google Scholar]
  13. Holmes E. C., Nee S., Rambaut A., Garnett G. P., Harvey P. H. 1995; Revealing the history of infectious disease epidemics through phylogenetic trees. Philos Trans R Soc Lond B Biol Sci 349:33–40 [CrossRef]
    [Google Scholar]
  14. Hudson R. R. 1991; Gene genealogies and the coalescent process. Oxford Surv Evol Biol 7:1–44
    [Google Scholar]
  15. Kalinina O., Norder H., Vetrov T., Zhdanov K., Barzunova M., Plotnikova V., Mukomolov S., Magnius L. O. 2001; Shift in predominating subtype of HCV from 1b to 3a in St Petersburg mediated by increase in injecting drug use. J Med Virol 65:517–524 [CrossRef]
    [Google Scholar]
  16. Kingman J. F. C. 1982; On the genealogy of large populations. J Appl Probab 19:27–43 [CrossRef]
    [Google Scholar]
  17. Kumar S., Tamura K., Nei M. 2004; mega3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5:150–163 [CrossRef]
    [Google Scholar]
  18. López-Labrador F. X., Ampurdanés S., Forns X., Castells A., Saiz J. C., Costa J., Bruix J., Sanchez Tapias J. M., Jimenez de Anta M. T., Rodes J. 1997; Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 27:959–965 [CrossRef]
    [Google Scholar]
  19. Memon M. I., Memon M. A. 2002; Hepatitis C: an epidemiological review. J Viral Hepat 9:84–100 [CrossRef]
    [Google Scholar]
  20. Mondelli M. U., Silini E. 1999; Clinical significance of hepatitis C virus genotypes. J Hepatol 31 (Suppl. 1):65–70 [CrossRef]
    [Google Scholar]
  21. Moreno Planas J. M., Fernández Ruiz M., Portero Azorín F., Boullosa Grana E., Rubio Gonzalez E., Martin Garcia S., Martinez Arrieta F., Jimenez Garrido M., Sanchez Turrion V., Cuervas-Mons Martinez V. 2005; Prevalence of hepatitis C virus genotypes in a Spanish liver transplant unit. Transplant Proc 37:1486–1487 [CrossRef]
    [Google Scholar]
  22. Mortimer P. P. 1995; Arsphenamine jaundice and the recognition of instrument-borne virus infection. Genitourin Med 71:109–119
    [Google Scholar]
  23. Moya A., Holmes E. C., González-Candelas F. 2004; The population genetics and evolutionary epidemiology of RNA viruses. Nat Rev Microbiol 2:279–288 [CrossRef]
    [Google Scholar]
  24. Nakano T., Lu L., Liu P., Pybus O. G. 2004; Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190:1098–1108 [CrossRef]
    [Google Scholar]
  25. Pawlotsky J. M., Tsakiris L., Roudot-Thoraval F., Pellet C., Stuyver L., Duval J., Dhumeaux D. 1995; Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171:1607–1610 [CrossRef]
    [Google Scholar]
  26. Payan C., Roudot-Thoraval F., Marcellin P., Bled N., Duverlie G., Fouchard-Hubert I., Trimoulet P., Couzigou P., Cointe D. other authors 2005; Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: the GEMHEP GenoCII Study. J Viral Hepat 12:405–413 [CrossRef]
    [Google Scholar]
  27. Pol S., Thiers V., Nousbaum J. B., Legendre C., Berthelot P., Kreis H., Brechot C. 1995; The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108:581–583 [CrossRef]
    [Google Scholar]
  28. Posada D., Crandall K. A. 1998; modeltest: testing the model of DNA substitution. Bioinformatics 14:817–818 [CrossRef]
    [Google Scholar]
  29. Pybus O. G., Rambaut A. 2002; genie: estimating demographic history from molecular phylogenies. Bioinformatics 18:1404–1405 [CrossRef]
    [Google Scholar]
  30. Pybus O. G., Rambaut A., Harvey P. H. 2000; An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155:1429–1437
    [Google Scholar]
  31. Pybus O. G., Charleston M. A., Gupta S., Rambaut A., Holmes E. C., Harvey P. H. 2001; The epidemic behavior of the hepatitis C virus. Science 292:2323–2325 [CrossRef]
    [Google Scholar]
  32. Pybus O. G., Drummond A. J., Nakano T., Robertson B. H., Rambaut A. 2003; The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 20:381–387 [CrossRef]
    [Google Scholar]
  33. Pybus O. G., Cochrane A., Holmes E. C., Simmonds P. 2005; The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5:131–139 [CrossRef]
    [Google Scholar]
  34. Rambaut A. 2000; Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16:395–399 [CrossRef]
    [Google Scholar]
  35. Ramos-Sánchez M. C., Torio-Cabezón R., Mazón-Ramos M. A., Martín-Gil F. J., del Alamo M. 2003; Hepatitis C virus genotype 4 in a North-west Spain district. J Clin Virol 28:223–224 [CrossRef]
    [Google Scholar]
  36. Rozas J., Sánchez-del Barrio J. C., Messeguer X., Rozas R. 2003; DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496–2497 [CrossRef]
    [Google Scholar]
  37. Santana Rodríguez O. E., Male Gil M. L., Hernández Santana J. F., Liminana Canal J. M., Martín Sánchez A. M. 1998; Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 14:555–561 [CrossRef]
    [Google Scholar]
  38. Schneider S., Roessli D., Excoffier L. 2000 arlequin version 2000: a software for population genetic data analysis Genetics and Biometry Laboratory. University of Geneva; Switzerland:
    [Google Scholar]
  39. Simmonds P. 2004; Genetic diversity and evolution of hepatitis C virus – 15 years on. J Gen Virol 85:3173–3188 [CrossRef]
    [Google Scholar]
  40. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399 [CrossRef]
    [Google Scholar]
  41. Simmonds P., Mellor J., Craxi A., Sanchez-Tapias J. M., Alberti A., Prieto J., Colombo M., Rumi M. G., Lo Iacano O. other authors 1996; Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 24:517–524 [CrossRef]
    [Google Scholar]
  42. Slatkin M. 1991; Inbreeding coefficients and coalescence times. Genet Res 58:167–175 [CrossRef]
    [Google Scholar]
  43. Smith D. B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P. L., Simmonds P. 1997; The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328
    [Google Scholar]
  44. Staden R., Beal K. F., Bonfield J. K. 2000; The Staden package, 1998. Methods Mol Biol 132:115–130
    [Google Scholar]
  45. Strimmer K., Pybus O. G. 2001; Exploring the demographic history of DNA sequences using the generalized skyline plot. Mol Biol Evol 18:2298–2305 [CrossRef]
    [Google Scholar]
  46. Swofford D. L. 2001 paup*: phylogenetic inference using parsimony (*and other methods), version 4 Sunderland, MA: Sinauer Associates;
    [Google Scholar]
  47. Tanaka Y., Hanada K., Mizokami M., Yeo A. E. T., Shih J. W.-K., Gojobori T., Alter H. J. 2002; A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99:15584–15589 [CrossRef]
    [Google Scholar]
  48. Tanaka Y., Agha S., Saudy N., Kurbanov F., Orito E., Kato T., Abo-Zeid M., Khalaf M., Miyakawa Y., Mizokami M. 2004; Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 58:191–195 [CrossRef]
    [Google Scholar]
  49. Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. 1997; The clustal_x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882 [CrossRef]
    [Google Scholar]
  50. Thomson B. J., Finch R. G. 2005; Hepatitis C virus infection. Clin Microbiol Infect 11:86–94 [CrossRef]
    [Google Scholar]
  51. Wasley A., Alter M. J. 2000; Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20:1–16 [CrossRef]
    [Google Scholar]
  52. Webster G., Barnes E., Brown D., Dusheiko G. 2000; HCV genotypes – role in pathogenesis of disease and response to therapy. Best Pract Res Clin Gastroenterol 14:229–240 [CrossRef]
    [Google Scholar]
  53. Wright S. 1951; The genetical structure of populations. Ann Eugen 15:323–354
    [Google Scholar]
  54. Wright S. 1965; The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution Int J Org Evolution 19:395–420 [CrossRef]
    [Google Scholar]
  55. Yu M. L., Chuang W. L., Chen S. C., Dai C. Y., Hou C., Wang J. H., Lu S. N., Huang J. F., Lin Z. Y. other authors 2001; Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 65:58–65 [CrossRef]
    [Google Scholar]
  56. Zein N. N. 2000; Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223–235 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82277-0
Loading
/content/journal/jgv/10.1099/vir.0.82277-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error